ROSEN, A TOP RANKED LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

A securities class action lawsuit has been filed against GeneDx Holdings Corp. for allegedly making false statements regarding the Fabric acquisition's impact on the company's financials and operations. Investors who purchased GeneDx common stock between April 16, 2025 and May 4, 2026 may be entitled to compensation. The lead plaintiff deadline is August 3, 2026.

06/23/2026, 6:47 PM • GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA

Pomerantz LLP has filed class action lawsuits against ADMA Biologics, GeneDx Holdings, and Helen of Troy Limited, alleging securities fraud and unlawful business practices. The lawsuit against ADMA was triggered by a Culper Research report alleging channel stuffing schemes, which caused the stock to fall 16.63% on March 24, 2026, followed by a 13.91% decline after a Cantor Fitzgerald downgrade on March 26, 2026. Investors have until August 10, 2026, to request Lead Plaintiff status.

06/23/2026, 4:50 PM • GlobeNewswire

GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics Acquisition – Hagens Berman

GeneDx Holdings (NASDAQ: WGS) faces a securities class action lawsuit after its stock plummeted 49% on May 5, 2026, following a disastrous Q1 2026 earnings report. The company recorded a $31.2 million impairment charge (94% write-off) on its Fabric Genomics acquisition and missed revenue growth targets, with guidance slashed by 12%. Investors allege the company misled them about Fabric's value, margin sustainability, and product mix changes.

06/22/2026, 3:35 PM • GlobeNewswire

Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office is Investigating Claims on Your Behalf

Grabar Law Office has filed multiple shareholder investigations and securities fraud class actions against Badger Meter, GeneDx Holdings, GRAIL Inc., and Verra Mobility Corporation, alleging that company officers and directors made false or misleading statements about financial performance, business acquisitions, clinical trial results, and contract renewals. All four companies experienced significant stock price declines following disclosure of the alleged misconduct.

06/22/2026, 10:56 AM • GlobeNewswire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Black Rock Coffee Bar, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BRCB

Rosen Law Firm has filed class action lawsuits against Black Rock Coffee Bar, Inc. (BRCB), GeneDx Holdings Corp. (WGS), and SES AI Corporation (SES) on behalf of investors who purchased securities during specified periods. The lawsuits allege that defendants made materially false and misleading statements regarding business operations and prospects. Black Rock Coffee is specifically accused of failing to disclose that new store openings caused cannibalization of existing revenue and overstating its expansion strategy effectiveness.

06/20/2026, 9:15 AM • GlobeNewswire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

Rosen Law Firm is soliciting investors who purchased GeneDx Holdings Corp. (NASDAQ: WGS) stock between April 16, 2025 and May 4, 2026 to join a securities class action lawsuit. The lawsuit alleges that GeneDx made false statements regarding the Fabric acquisition's positive impact on the company's financials and operations, when in reality the company knew of significant viability problems that would negatively impact the business. The lead plaintiff deadline is August 3, 2026.

06/20/2026, 8:44 AM • GlobeNewswire

רוזן, משרד עורכי דין מוביל לזכויות משקיעים, מעודד את משקיעי Via Transportation, Inc לקבל ייעוץ משפטי לפני המועד האחרון החשוב בתביעה ייצוגית לניירות ערך - VIA

Rosen Law Firm, a leading investor rights law firm, has announced class action securities lawsuits against Via Transportation, Inc., GeneDx Holdings Corp., and BitGo Holdings, Inc. The Via lawsuit alleges that IPO registration documents contained false and misleading statements about the company's growth challenges and revenue decline. Investors who purchased shares during the class period may be eligible for compensation. The deadline to serve as lead plaintiff in the Via case is August 10, 2026.

06/18/2026, 12:27 AM • GlobeNewswire

רוזן, יועץ למשקיעים גלובלי, מעודד את משקיעי GeneDx Holdings Corp. לקבל ייעוץ משפטי לפני מועד חשוב בתביעה ייצוגית בניירות ערך – WGS

Rosen Law Firm is reminding shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) who purchased shares between April 16, 2025 and May 4, 2026 about an important August 3, 2026 deadline to file a securities class action lawsuit. The lawsuit alleges that GeneDx made false statements regarding the Fabric acquisition's financial benefits and operational synergies, while concealing material issues that negatively impacted the company's business.

06/17/2026, 11:33 PM • GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

GeneDx Holdings Corp. faces a securities fraud class action lawsuit for failing to disclose material information about its acquisition performance. The company reported a significant drop in adjusted gross margin from 74% to 69%, missed revenue estimates, and disclosed a $31.2 million impairment loss on its Fabric Genomics acquisition. GeneDx shares fell 49.2% on May 4, 2026, following the disappointing financial results and lowered guidance.

06/16/2026, 11:31 PM • GlobeNewswire

WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

GeneDx Holdings Corp. (WGS) faces a securities class action lawsuit after its stock plummeted 49.20% ($33.42 per share) on May 4, 2026. The company disclosed a $31.2 million impairment charge related to its Fabric Genomics acquisition, slashed full-year revenue guidance by $65 million, and revealed the acquisition failed to deliver promised value. Investors who purchased shares between April 16, 2025 and May 4, 2026 may be eligible to participate in the lawsuit, with the lead plaintiff deadline set for August 3, 2026.

06/15/2026, 3:55 PM • GlobeNewswire

ROSEN, LEADING TRIAL ATTORNEYS, Encourages BitGo Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTGO

Rosen Law Firm has filed class action lawsuits against BitGo Holdings, GeneDx Holdings, and Via Transportation on behalf of investors. The BitGo lawsuit alleges that offering documents contained materially false statements regarding the company's assessment of risks posed by declining digital asset prices to its business and financial performance. Investors who purchased securities during specified periods may be eligible for compensation.

06/14/2026, 6:09 PM • GlobeNewswire

ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

Rosen Law Firm has filed a class action lawsuit against GeneDx Holdings Corp. on behalf of investors who purchased common stock between April 16, 2025 and May 4, 2026. The lawsuit alleges that GeneDx made false statements regarding the Fabric acquisition's positive impact on the company's financials and operational efficiencies, while knowingly concealing significant viability problems that would negatively affect the business. Investors who suffered losses may be eligible for compensation.

06/14/2026, 12:23 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) alleging that the company made materially false and misleading statements regarding Fabric Genomics, reimbursement rates durability, and gross margins during the period from April 16, 2025 to May 4, 2026. Investors who purchased GeneDx securities during this period are encouraged to join the case, with a lead plaintiff deadline of August 3, 2026.

06/14/2026, 12:00 PM • GlobeNewswire

NASDAQ: WGS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against GeneDx Holdings Corp. (WGS)

A securities fraud class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) for allegedly making material misstatements about the viability of its $51 million acquisition of Fabric Genomics. On May 4, 2026, GeneDx disclosed a $31.3 million impairment loss on Fabric and missed earnings projections, causing the stock to plunge 49%. Investors who purchased WGS stock between April 16, 2025, and May 4, 2026, can seek lead plaintiff status by August 3, 2026.

06/13/2026, 11:30 AM • GlobeNewswire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

Rosen Law Firm has filed a class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS) on behalf of investors who purchased common stock between April 16, 2025 and May 4, 2026. The lawsuit alleges that GeneDx made false statements regarding the Fabric acquisition's impact on the company's financials and operational efficiencies, while knowingly concealing significant viability problems that negatively affected the business. Investors must move the court by August 3, 2026 to serve as lead plaintiff.

06/11/2026, 3:51 PM • GlobeNewswire